InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
17,011.20
(
0.89%
)
Dow Jones
37,903.29
(
0.00%
)
Brent Oil
84.32
(
0.93%
)
Bitcoin
58,728.82
(
0.84%
)
Post# of 251673
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

WorstLuck

Send PM Follow Ignore
Followers 9
Posts 985
Boards Moderated 0
Alias Born 02/23/2010

WorstLuck

Re: None

Sunday, 10/23/2022 11:49:58 PM

Sunday, October 23, 2022 11:49:58 PM

Post# of 251673
MYOV

https://investors.myovant.com/news-releases/news-release-details/sumitovant-biopharma-sumitomo-pharma-and-myovant-sciences-enter/


Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement
October 23, 2022 at 11:30 PM EDT

Sumitovant Biopharma to Acquire all Outstanding Shares of Myovant for $27 Per Share in Cash

Combination Provides Expertise and Resources to Address Unmet Patient Needs in Women's Health and Prostate Cancer

Agreement Unanimously Recommended by Special Committee of Myovant's Independent Directors and Approved by Board
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up